Find clinical trials for Glioblastoma (GBM) in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma

Recurrence

Glioma

Brain Cancer

Astrocytoma

Cancer

Gliosarcoma

Glioblastoma (GBM) trials near Cincinnati, OH, USA:

GammaTile and Stupp in Newly Diagnosed GBM (GESTALT)

In summary, standard of care postoperative chemoradiation for patients with newly diagnosed GBM does not routinely provide durable local con...

Enrolling

Glioblastoma

Device: Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

Phase 4

GT Medical Technologies

Kettering, Ohio, United States and 11 other locations

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations (FIGHT-209)

This is an open-label, monotherapy study of pemigatinib in participants with recurrent glioblastoma (GBM) or other recurrent glioma...

Active, not recruiting

Glioblastoma

Adult-type Diffuse Gliomas

Drug: Pemigatinib

Phase 2

Incyte

Cincinnati, Ohio, United States and 80 other locations

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

The purpose of this study is to assess progression-free survival (PFS) and overall survival (OS) in newly diagnosed Glioblastoma (GBM...

Active, not recruiting

Glioblastoma

Combination Product: IGV-001 Cell Immunotherapy

Drug: SOC: Temozolomide

Phase 2

Imvax

Cincinnati, Ohio, United States and 22 other locations

Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant with RT & TMZ for the Treatment of Newly Diagnosed GBM (EF-32)

To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...

Active, not recruiting

Glioblastoma Multiforme

Device: Optune®

NovoCure

Cincinnati, Ohio, United States and 132 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Glioblastoma (GBM) in .css-epvm6{white-space:nowrap;}Cincinnati, OH

Related conditions:

Glioblastoma (GBM) trials near Cincinnati, OH, USA:

GammaTile and Stupp in Newly Diagnosed GBM (GESTALT)

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations (FIGHT-209)

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant with RT & TMZ for the Treatment of Newly Diagnosed GBM (EF-32)

Find clinical trials for Glioblastoma (GBM) in Cincinnati, OH